<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Tokyo_Tech_Composite_Part skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Tokyo Tech/Composite Part</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="main_contents"><DIV id="page_header" class="container container_top"><H1 align="center">Composite Parts</H1></DIV><DIV id="prhl" class="container"><DIV id="prhl_header" class="container_header"><H1><SPAN class="underline">Prhl(NM)-<SPAN style="font-style: italic;">rbs-gfp</SPAN>: <A href="http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</A></SPAN></H1></DIV><DIV id="prhl_contents" class="container_contents"><H2 align="center"><A href="http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</A> meets the Silver Medal criteria!</H2><P class="normal_text">We simulated our final genetic circuits and found that the circuits would not work, because Prhl (<A href="http://parts.igem.org/Part:BBa_I14017">BBa_I14017</A>) strength was too weak. (see <A href="https://2016.igem.org/Team:Tokyo_Tech/Model"> the Model page </A> and <A href="https://2016.igem.org/Team:Tokyo_Tech/AHL_Assay/Only_Assay">the AHL only assay page</A>). We therefore considered using the improved Prhl (<A href="http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</A>,　<A href="http://parts.igem.org/Part:BBa_K1529310">BBa_K1529310</A>) established by iGEM 2014 team Tokyo_Tech, but we noticed that they were inappropriate for two reasons (see our work <A href="https://2016.igem.org/Team:Tokyo_Tech/AHL_Assay/Rhl_System_Assay">Rhl system assay</A>). Then, we decided to further improve this Prhl and obtain our original improved Prhl (included in <A href="http://parts.igem.org/BBa_K1949060">BBa_K1949060</A>) that suited our goal.
 Our purpose is to create a strong Prhl for our final genetic circuits.
This experiment consists of the three parts below.</P><P class="normal_text">For more information, read <A href="http://parts.igem.org/Part:BBa_K1949060">this page</A> !</P><OL type="I"><LI><P class="normal_text">Improvement of iGEM 2014 team Tokyo_Tech's Prhl(<A href="http://parts.igem.org/BBa_K1529300">BBa_K1529300</A>, <A href="http://parts.igem.org/BBa_K1529310">BBa_K1529310</A>) and characterize RhlR assay (Fig.4-3-1)</P></LI><DIV align="center"><P class="caption" style="font-size: 16px; text-align: center;"><SPAN style="font-weight: bold;">Fig. 4-3-1 Effect of RhlR by tagging LVA and The colonies of transformants with a rhlR (left) or a rhlR - LVA (right)</SPAN></P><P class="normal_text">Improvement of the wild type Prhl(<A href="http://parts.igem.org/BBa_I14017">BBa_I14017</A>) (Fig.4-3-2)</P><DIV align="center"><P class="caption" style="font-size: 16px; text-align: center;"><SPAN style="font-weight: bold;">Fig. 4-3-2 RFU of GFP / Turbidity of imoroved Prhl mutants</SPAN></P><P class="normal_text">Comparison of iGEM 2014 team Tokyo_Tech's Prhl to our original improved Prhl (included in <A href="http://parts.igem.org/BBa_K1949060">BBa_K1949060</A>) (Fig.4-3-3)</P><DIV align="center"><P class="caption" style="font-size: 16px; text-align: center;"><SPAN style="font-weight: bold;">Fig. 4-3-3 Comparison of Prhl(NM) by Prhl(LR)</SPAN></P><P class="normal_text">The past improved Prhl did not suit for our final circuits and we could construct the improved Prhl appropriate to our final circuits.</P></DIV></DIV><DIV id="other_composite_parts" class="container"><DIV id="other_composite_parts_header" class="container_header"><H1><SPAN style="border-bottom: solid 2px;">Tokyo Tech 2016 iGEM Team: The Others Composite Parts</SPAN></H1></DIV><DIV id="other_composite_parts_contents" class="container_contents"><TABLE class="parts_table"><TBODY><TR><TH class="parts_table_name">Name</TH><TH class="parts_table_type">Type</TH><TH class="parts_table_description">Description</TH><TH class="parts_table_design">Design</TH><TH class="parts_table_length">Length(bp)</TH></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949001">BBa_K1949001</A></TD><TD>Measurement</TD><TD>Pcold-<SPAN style="font-style:italic;">gfp</SPAN></TD><TD>Yoshio Takata</TD><TD>1033</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949032">BBa_K1949032</A></TD><TD>Composite</TD><TD>PBAD-<SPAN style="font-style:italic;">rbs-yafO</SPAN></TD><TD>Yoshio Takata</TD><TD>1638</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949033">BBa_K1949033</A></TD><TD>Composite</TD><TD>PBAD-<SPAN style="font-style:italic;">rbs-yafO-tt</SPAN>-Ptet-<SPAN style="font-style:italic;">rbs-gfp</SPAN></TD><TD>Yoshio Takata</TD><TD>2580</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949052">BBa_K1949052</A></TD><TD>Composite</TD><TD>PBAD-<SPAN style="font-style:italic;">rbs-amiE</SPAN></TD><TD>Yoshio Takata</TD><TD>2712</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949060">BBa_K1949060</A></TD><TD>Composite</TD><TD>Prhl(NM)-<SPAN style="font-style:italic;">rbs</SPAN>-<SPAN style="font-style:italic;">gfp</SPAN></TD><TD>Yoshio Takata</TD><TD>799</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949100">BBa_K1949100</A></TD><TD>Composite</TD><TD>Plac-<SPAN style="font-style:italic;">rbs-mazE</SPAN></TD><TD>Yoshio Takata</TD><TD>565</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949101">BBa_K1949101</A></TD><TD>Composite</TD><TD>PBAD-<SPAN style="font-style:italic;">rbs-mazF</SPAN></TD><TD>Yoshio Takata</TD><TD>1575</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</A></TD><TD>Composite</TD><TD>PBAD-<SPAN style="font-style:italic;">rbs</SPAN>-<SPAN style="font-style:italic;">mazF</SPAN>-<SPAN style="font-style:italic;">tt</SPAN>-Ptet-<SPAN style="font-style:italic;">rbs</SPAN>-<SPAN style="font-style:italic;">gfp</SPAN></TD><TD>Yoshio Takata</TD><TD>2520</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949103">BBa_K1949103</A></TD><TD>Composite</TD><TD>Ptet-<SPAN style="font-style:italic;">rbs</SPAN>(<A href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034)</A>)-<SPAN style="font-style:italic;">mazE</SPAN></TD><TD>Yoshio Takata</TD><TD>332</TD></TR><TR><TD><A href="http://parts.igem.org/Part:BBa_K1949104">BBa_K1949104</A></TD><TD>Composite</TD><TD>Ptet-<SPAN style="font-style:italic;">rbs</SPAN>(<A href="http://parts.igem.org/Part:BBa_J61117">BBa_J61117</A>)-<SPAN style="font-style:italic;">mazE</SPAN></TD><TD>Yoshio Takata</TD><TD>332</TD></TR></TBODY></TABLE></DIV></DIV><DIV id="yafon_parts" class="container"><DIV id="yafon_parts_header" class="container_header"><SPAN style="border-bottom: solid 2px;"><H1><I>yafON</I> Composite Parts: <A href="http://parts.igem.org/Part:BBa_K1949032">BBa_K1949032</A> and <A href="http://parts.igem.org/Part:BBa_K1949033">BBa_K1949033</A></H1></SPAN></DIV><DIV id="yafon_parts_contents" class="container_contents"><H2 align="center"><A href="http://parts.igem.org/Part:BBa_K1949032">BBa_K1949032</A> meets the Silver Medal criteria! </H2><P class="normal_text">YafN is an antitoxin corresponding to toxin YafO, and YafN reverses inhibition of cell growth. <SPAN style="font-style: italic;">yafN</SPAN> and <SPAN style="font-style: italic;">yafO</SPAN> exist as an operon, and YafN also functions as a repressor in the operon. Therefore, <SPAN style="font-style: italic;">yafNO</SPAN> operon’s translation is autoregulated by antitoxin YafN. When Lon protease senses environmental stresses such as DNA damage, the operon becomes active because of degradation of YafN by Lon protease. </P><H3>Confirming <I>Yafo</I> Function as Toxin on Agar Medium</H3><P class="normal_text"> We first confirmed YafO function by observing formation of colonies on agar plate. This experiment was carried out using <SPAN style="font-style: italic;">E. coli</SPAN> which inducible <SPAN style="font-style: italic;">yafO</SPAN> expression by arabinose and <SPAN style="font-style: italic;">E. coli</SPAN> without <SPAN style="font-style: italic;">yafO</SPAN> gene. Construction of plasmids used in this experiment is shown in below. We inoculated four types of <SPAN style="font-style: italic;">E. coli</SPAN> differently on agar plate with and without arabinose. As a result(Fig. 4-3-4), all types of <SPAN style="font-style: italic;">E. coli</SPAN> were able to form colonies on agar plate with no arabinose, and colonies of <SPAN style="font-style: italic;">E. coli</SPAN> (c) and (d) had RFU (Relative Fluorescence Units). On the other hand, <SPAN style="font-style: italic;">E. coli</SPAN> (a) and (c) couldn’t form any colonies on agar plate containing arabinose. From these results, we confirmed that all types of <SPAN style="font-style: italic;">E. coli</SPAN> in below functions as we expected.</P><DIV align="center"><P class="caption" style="font-size: 16px; text-align: center;"><SPAN style="font-weight: bold;">Fig. 4-3-4 Confirming YafO function as toxin on agar plates</SPAN></P></DIV><H3>Toxin-antitoxin assay</H3><P class="normal_text">From previous experiment, we were able to confirm that YafO works as toxin. Next, we confirmed whether the cell growth reverses by antitoxin YafN after inhibition by YafO. Construction of plasmids used in this experiment is shown in below. We prepared <SPAN style="font-style: italic;">E. coli</SPAN> which can induce expression of <SPAN style="font-style: italic;">yafO</SPAN> by arabinose and YafN by lactose. As comparisons, we also carried out same experiment with <SPAN style="font-style: italic;">E. coli</SPAN> containing no <SPAN style="font-style: italic;">yafO</SPAN> gene, no <SPAN style="font-style: italic;">yafN</SPAN> gene and none of them. As a result(Fig. 4-3-5), we couldn’t observe cell growth reversing after adding IPTG to induce expression of <SPAN style="font-style: italic;">yafN</SPAN>, and their turbidity became constant as <SPAN style="font-style: italic;">E. coli</SPAN> (c) containing no <SPAN style="font-style: italic;">yafN</SPAN>. In this experiment, YafN couldn’t reverse the cell growth after inhibition by YafO. It seems to be difficult to control cell growth just like <SPAN style="font-style: italic;">mazEF</SPAN> system, which demonstrated reverse of cell growth by antitoxin after function of toxin.</P><DIV align="center"><P class="caption" style="font-size: 16px; text-align: center;"><SPAN style="font-weight: bold;">Fig. 4-3-5 toxin-antitoxin assay</SPAN></P></DIV><P class="normal_text">For more information, read <A href="http://parts.igem.org/Part:BBa_K1949020">BBa_K1949020</A>, <A href="http://parts.igem.org/Part:BBa_K1949030">BBa_K1949030</A> !</P></DIV></DIV><DIV id="mazfe_parts" class="container"><DIV id="mazfe_parts_header" class="container_header"><H1 style="height: 100px; margin: 1px; padding: 0; line-height: 50px;"><SPAN><I>mazFE</I> Composite Parts: <A href="http://parts.igem.org/Part:BBa_K1949100">BBa_K1949100</A>, <A href="http://parts.igem.org/Part:BBa_K1949101">BBa_K1949101</A>, <A href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</A>, <A href="http://parts.igem.org/Part:BBa_K1949103">BBa_K1949103</A> and <A href="http://parts.igem.org/Part:BBa_K1949104">BBa_K1949104</A></SPAN></H1></DIV><DIV id="mazfe_parts_contents" class="container_contents"><H2 align="center"><A href="http://parts.igem.org/Part:BBa_K1949100">BBa_K1949100</A>,<A href="http://parts.igem.org/Part:BBa_K1949101">BBa_K1949101</A> and <A href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</A> meets the Bronze Medal criteria!</H2><H2 align="center"><A href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</A> is our Best Composite Parts !</H2><H3>Stop &amp; Go</H3><P class="normal_text">The biggest attraction of the TA system is that it is able to control cell growth and synthesis of protein. In this experiment, <I>mazE</I> expression was induced by the addition of IPTG(2 mM) after <I>mazE</I> expression was induced by the addition of arabinose(0.02%). As a result, it was able to resuscitate from a state of being inhibited cell growth. We named this experiment as &quot;Stop &amp; Go&quot; because it was to resuscitate growth from inhibiting cell growth.</P><P class="normal_text">It was found from Fig. 4-3-5 that MazF inhibited cell growth. MazE was induced 2 h after <SPAN style="font-style:italif;">maze</SPAN> expression, and about 8 h later, cell growth was recovered that had stopped. From these results, it was suggested that <SPAN style="font-style: italic;">E. coli</SPAN> whose cell growth was inhibited by MazF was able to resuscitate by expression of <SPAN style="font-style: italic;">mazE</SPAN>. 

</P><DIV align="center"><P class="caption" style="font-size: 16px; text-align: center;"><SPAN style="font-weight: bold;">Fig. 4-3-5 Time vs Turbidity (Stop &amp; Go) and Time vs RFU of GFP (Stop &amp; Go)</SPAN></P><P class="normal_text">For more information, read <A href="http://parts.igem.org/Part:BBa_K1949100">BBa_K1949100</A>, <A href="http://parts.igem.org/Part:BBa_K1949101">BBa_K1949101</A> and <A href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</A>.</P></DIV><H3>Go &amp; Stop</H3><P class="normal_text">We found that a toxin inhibits cell growth, and an antitoxin resuscitates it. However, what will happen when a toxin is expressed after the antitoxin constitutive expression? Therefore, we conducted the experiment. Since cell growth was resuscitated after cells had grown, we named this experiment, &quot;Go &amp; Stop&quot;.</P><P class="normal_text"> From  Fig.4-3-6, <SPAN style="font-style: italic;">E. coli</SPAN> encoded <SPAN style="font-style: italic;">mazE</SPAN> which is on downstream of weak RBS(<A href="http://parts.igem.org/Part:BBa_J61117">BBa_J61117</A>) has more turbidity than <SPAN style="font-style: italic;">E. coli</SPAN> encoded <SPAN style="font-style: italic;">mazE</SPAN> which is on downstream of normal RBS(<A href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</A>). Both of those <SPAN style="font-style: italic;">E. coli</SPAN> would reach stationary phase when there is little RFU of GFP(Fig. 4-3-6). <SPAN style="font-style: italic;">E. coli</SPAN> encoded <SPAN style="font-style: italic;">mazE</SPAN> which is on downstream of normal RBS reached almost the same stationary phase as <SPAN style="font-style: italic;">E. coli</SPAN> without TA system.</P><DIV align="center"><P class="caption" style="font-size: 16px; text-align: center;"><SPAN style="font-weight: bold;">Fig. 4-3-6 Time vs Turbidity (Go &amp;Stop) and Time vs RFU of GFP (Go &amp;Stop)</SPAN></P></DIV><P class="normal_text">For more information, <A href="http://parts.igem.org/Part:BBa_K1949101">BBa_K1949101</A>, <A href="http://parts.igem.org/Part:BBa_K1949102">BBa_K1949102</A>, <A href="http://parts.igem.org/Part:BBa_K1949103">BBa_K1949103</A> and <A href="http://parts.igem.org/Part:BBa_K1949104">BBa_K1949104</A>.</P></DIV></DIV></DIV></OL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>